Tech Company Financing Transactions
Chromatin Funding Round
IllinoisVENTURES, private investors and Unilever participated in a $10 million Series D funding round for Chromatin. The financing round was announced on 10/25/2011.
Transaction Overview
Company Name
Announced On
10/25/2011
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series D
Investors
Proceeds Purpose
The additional capital will help fund Chromatin's programs to develop supply chains of energy crop feedstocks for producers of renewable energy.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10 South La Salle St. 2100
Chicago, IL 60603
USA
Chicago, IL 60603
USA
Phone
Website
Email Address
Overview
Chromatin, Inc. is focused on developing sorghum, both for traditional agriculture and for uses in new applications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daphne Preuss
VP - Bus. Development
Michael Battin
VP - Bus. Development
Charles Miller
VP - Operations
Larry McDowell
VP - R & D
Scott Staggenborg
Browse more venture capital transactions:
Prev: 10/25/2011: Main Street Hub venture capital transaction
Next: 10/25/2011: OwnLocal venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs